Categories : Anti-Infectives
Product Packaging : 1 vial each
Product Composition : 281.25 mg , 562.5 mg, 1125 mg
Send MessageGenliva Wellness exports Cefepime & Tazobactam Injection for management of serious bacterial infections requiring broad-spectrum injectable antibiotic therapy in hospital and critical care settings. The formulation is extensively used in ICU infections, lower respiratory tract infections, septicemia, complicated urinary tract infections, and hospital-acquired bacterial conditions.
Cefepime is a fourth-generation cephalosporin antibiotic with strong activity against gram-positive and gram-negative bacteria, while Tazobactam enhances antibacterial effectiveness by inhibiting beta-lactamase resistance enzymes. As a recognized Critical Care Antibiotic Injection Exporter, Genliva Wellness develops sterile injectable formulations designed for advanced hospital infection management.
Operating as a Cefepime & Tazobactam Injection Manufacturer in India, Genliva Wellness LLP supplies critical care injectable antibiotics to pharmaceutical distributors and international healthcare institutions.
Cefepime & Tazobactam Injection is formulated for severe bacterial infection and critical care treatment.
This injectable formulation is commonly used for hospital and severe bacterial infection treatment.
Cefepime & Tazobactam Injection provides advanced injectable antibacterial coverage for critical infections.